Evidence map›Paper›PMID 22672413›Full record

ArticleBMC microbiology2012

Unbalance of intestinal microbiota in atopic children.

Marco Candela, Simone Rampelli, Silvia Turroni, Marco Severgnini, Clarissa Consolandi, Gianluca De Bellis, Riccardo Masetti, Giampaolo Ricci, Andrea Pession, Patrizia Brigidi

Registry-linked trialAbstract read
In one paragraph

Article in BMC microbiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03962335 (ModulAtion of Gut Microbiota Through Nutritional Interventions in Behcet's Syndrome pAtients), which is not on this map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03962335 nacompletednot on this mapstarted 2019, after this paper: background citation

ModulAtion of Gut Microbiota Through Nutritional Interventions in Behcet's Syndrome pAtients: the MAMBA Study

TypeinterventionalSponsorAzienda Ospedaliero-Universitaria CareggiRan2019 to 2023Enrolled90ConditionsBehcet SyndromeArmsVegetarian diet, Mediterranean diet with butyrate, Mediterranean diet
3 · Its place in the literature

Who cites it

72 citing papers in PubMed.

  1. Therapeutic effects elicited by the probiotic Lacticaseibacillus rhamnosus GG in children with atopic dermatitis. The results of the ProPAD trial.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2022
    Trial
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Frontiers in microbiology · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Marco CandelaDepartment of Pharmaceutical Sciences, University of Bologna, Bologna, Italy. marco.candela@unibo.it
Simone Rampelli
Silvia Turroni
Marco Severgnini
Clarissa Consolandi
Gianluca De Bellis
Riccardo Masetti
Giampaolo Ricci
Andrea Pession
Patrizia Brigidi

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlaying a strategic role in the host immune function, the intestinal microbiota has been recently hypothesized to be involved in the etiology of atopy. In order to investigate the gastrointestinal microbial ecology of atopic disease, here we performed a pilot comparative molecular analysis of the faecal microbiota in atopic children and healthy controls.

resultsNineteen atopic children and 12 healthy controls aged 4-14 years were enrolled. Stools were collected and the faecal microbiota was characterized by means of the already developed phylogenetic microarray platform, HTF-Microbi.Array, and quantitative PCR. The intestinal microbiota of atopic children showed a significant depletion in members of the Clostridium cluster IV, Faecalibacterium prausnitzii, Akkermansia muciniphila and a corresponding increase of the relative abundance of Enterobacteriaceae.

conclusionDepleted in key immunomodulatory symbionts, the atopy-associated microbiota can represent an inflammogenic microbial consortium which can contribute to the severity of the disease. Our data open the way to the therapeutic manipulation of the intestinal microbiota in the treatment of atopy by means of pharmaceutical probiotics.

Indexed as

BiotaMetagenomeAdolescentChildChild, PreschoolFecesFemaleGastrointestinal TractHumansHypersensitivityMaleMicroarray Analysis

Identifiers

PMID22672413
PMCPMC3404014

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.